Patient Monitoring Devices Market by Device (Hemodynamic, Neuromonitoring, Cardiac, Respiratory, Multiparameter, Remote Patient Monitors, Temperature, Fetal & Neonatal and Weight Management Monitors) and End User - Global Opportunity Analysis and Industry Forecast, 2014 - 2022

Patient monitoring devices are used during minor & major surgeries to monitor a patient’s physiological signs and related complications. Moreover, with the advancements in wireless technology, these devices can be used to remotely monitor the physiological parameters of the patients. These devices are a critical part of hospitals and other healthcare facilities as these are expected to help physicians determine the severity of a disease. These devices help doctors and other healthcare professionals detect and monitor the health of the patients suffering from various types of diseases such as diabetes and cardiovascular diseases.

The report analyzes the patient monitoring devices market into three segments, namely, product type, end user, and geography. On the basis of product type, it is divided into nine segments; hemodynamic, neuromonitoring, cardiac, fetal & neonatal, respiratory, multiparameter, remote patient, weight, and temperature monitoring devices. Hemodynamic monitoring devices can be further segmented into blood glucose, blood gas & electrolyte analyzer, and blood pressure monitors. Neuromonitoring devices is further categorized into electroencephalograph devices, magnetoencephalography devices, intracranial pressure monitors, transcranial Dopplers, and cerebral oximeters. Cardiac monitoring devices are further divided into electrocardiogram devices, Holter monitors, event monitors, and others (implantable loop recorders, cardiac output monitoring devices, and others). Fetal & neonatal monitoring devices are further categorized into ultrasound fetal Doppler, Electronic Fetal Monitoring devices (EFM), Fetal Doppler and Others. Respiratory monitoring devices are further segmented into capnograph, spirometer, sleep apnea monitor, and pulse oximeter. Multiparameter monitoring devices are further categorized into high, mid, and low acuity. Based on end users, the market is categorized into three segments; hospitals & clinics, home settings, and ambulatory surgical centers. Based on geography, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The global patient monitoring devices market is driven by increase in the geriatric population, growth in the prevalence of patients suffering from different lifestyle diseases, and rise in the adoption rate of remote patient monitoring devices. However, the cost associated with this technology and issues related to government regulations & reimbursements are expected to hamper the global market growth. With the advancement in wireless technology, these devices are used to remotely monitor the physiological parameters of the patients, such as blood glucose level, blood pressure, heart rate, and provide appropriate treatment to the patients.

 

The growth in competition has led to collaborations and product launch by key players in the patient monitoring devices market. Moreover, Nihon Kohden announced the launch of the advanced bedside monitor called BSM-3500. These monitors are designed to meet the needs of ambulatory surgery and specialty centers. BSM-3500 monitors help to provide a range of standard monitoring facilities and many critical capabilities in low acuity settings.

 

 

• The global patient monitoring devices market report provides an extensive analysis of the current market trends and future estimations in the market.
• The market scenario is comprehensively analyzed with respect to the product and end users.
• The market estimations are based on high-end analysis of the key developments.
• Recent developments and key manufacturers are listed to understand the competitive market scenario.
• In-depth analysis based on geography provides an understanding of the regional market, which assists in strategic business planning.

 

 

• Medtronic, Inc.
• Biotronik
• F. Hoffmann-La Roche Ltd.
• GE Healthcare Ltd.
• Masimo Corporation
• Nihon Kohden Corporation
• Johnson and Johnson
• Omron Healthcare Co. Ltd.
• Abbott Laboratories
• Koninklijke Philips N.V.

 

 

 

• Hemodynamic Monitoring Devices
  • Blood Glucose
  • Cholesterol
  • Blood Gas & Electrolyte Analyzers/Monitors
  • Blood Pressure
• Neuromonitoring Devices
  • Electroencephalograph (EEG) Devices
  • Magnetoencephalograph (MEG) Devices
  • Intracranial Pressure Monitors (ICP)
  • Transcranial Dopplers (TCD)
  • Cerebral Oximeters
• Cardiac Monitoring Devices
  • Electrocardiogram (ECG) Devices
  • Implantable Loop Recorders (ILR)
  • Cardiac Output Monitoring (COM) Devices
  • Event Monitors
• Fetal & Neonatal Monitoring Devices
  • Ultrasound
  • Electronic Fetal Monitoring Devices
  • Fetal Doppler Monitoring Devices
  • Other Fetal & Neonatal Monitoring Devices
• Respiratory Monitoring Devices
  • Capnographs
  • Anesthesia Monitors
  • Spirometers
  • Pulse Oximeters
  • Sleep Apnea Monitoring Devices
• Multiparameter Monitoring Devices
  • High Acuity
  • Mid Acuity
  • Low Acuity
• Remote Patient Monitoring Devices
• Weight Monitoring Devices
• Temperature Monitoring Devices
• Urine Output Monitoring Devices

 

• Hospitals & Clinics
• Home Settings
• Ambulatory Surgical Centers (ASC)

 

        U.S.

        Canada

        Mexico

        Germany

        UK

        France

        Spain

        Italy

        Russia

        Rest of Europe

    Asia-Pacific

        Japan

        China

        Australia

        India

        South Korea

        Taiwan

        Rest of Asia-Pacific

        Brazil

        Turkey

        Venezuela

        Republic of South Africa

        Saudi Arabia

        Rest of LAMEA

 

 

• Honeywell International Inc.
• Siemens Healthcare
• Lifewatch AG
• Care Innovations, LLC.
• St. Jude Medical, Inc.
• Smiths Medical

 

1.1 REPORT DESCRIPTION

1.2 KEY BENEFITS

1.3 KEY MARKET SEGMENTS

1.4 RESEARCH METHODOLOGY

1.4.1 Secondary research

1.4.2 Primary research

1.4.3 Analyst tools and models

 

2.1 CXO PERSPECTIVE

 

3.1 MARKET DEFINITION AND SCOPE

3.2 KEY FINDINGS

3.2.1 Top investment pockets

3.2.2 Top winning strategies

3.3 GOVERNMENT REGULATIONS

3.3.1 U.S. FDA

3.3.2 Europe CE mark

3.3.3 Ministry of Health, Labor, and Welfare (MHLW)

3.4 REIMBURSEMENT SCENARIOS

3.5 CLINICAL TRIALS

3.6 PATENT ANALYSIS

3.6.1 U.S. patent analysis, by market participant

3.6.2 Europe patent analysis, by market participant

3.6.3 China patent analysis, by market participant

3.6.4 Canada patent analysis, by market participant

3.6.5 Japan patent analysis by market participant

3.6.6 Other countries patent analysis, by market participant

3.7 TOP IMPACTING FACTORS

3.7.1 Drivers

3.7.1.1 Rise in the prevalence of lifestyle diseases

3.7.1.2 Increase in the geriatric population

3.7.1.3 Rise in the adoption rate of remote patient monitoring devices

3.7.2 Restrains

3.7.2.1 Government regulations and reimbursement issues

3.7.2.2 Limited awareness and high costs

3.7.3 Opportunities

3.7.3.1 Untapped markets in developing countries

3.7.3.2 Technological advancements

 

4.1 OVERVIEW

4.1.1 Market size and forecast

4.2 HEMODYNAMIC MONITORING DEVICES

4.2.1 Key market trends

4.2.2 Key growth factors and opportunities

4.2.3 Market size and forecast

4.2.4 Blood glucose monitors

4.2.4.1 Market size and forecast

4.2.5 Blood gas and electrolyte analyzers/monitors

4.2.5.1 Market size and forecast

4.2.6 Blood pressure monitors

4.2.6.1 Market size and forecast

4.3 NEUROMONITORING DEVICES

4.3.1 Key market trends

4.3.2 Key growth factors and opportunities

4.3.3 Market size and forecast

4.3.4 Electroencephalograph (EEG) devices

4.3.4.1 Market size and forecast

4.3.5 Transcranial dopplers (TCD)

4.3.5.1 Market size and forecast

4.3.6 Magnetoencephalograph (MEG) devices

4.3.6.1 Market size and forecast

4.3.7 Intracranial pressure monitors (ICP)

4.3.7.1 Market size and forecast

4.3.8 Cerebral oximeters

4.3.8.1 Market size and forecast

4.4 CARDIAC MONITORING DEVICES

4.4.1 Key market trends

4.4.2 Key growth factors and opportunities

4.3.3 Market size and forecast

4.4.4 Electrocardiogram (ECG) devices

4.4.4.1 By type

4.4.4.2 By lead type

4.4.4.3 Market size and forecast

4.4.5 Holter monitors

4.4.5.1 Market size and forecast

4.4.6 Event monitors

4.4.6.1 By type

4.4.6.2 By technology

4.4.6.3 Market size and forecast

4.4.7 Others (Implantable loop recorder, Cardiac output monitor and others)

4.4.7.1 Market size and forecast

4.5 FETAL AND NEONATAL MONITORING DEVICES

4.5.1 Key market trends

4.5.2 Key growth factors and opportunities

4.5.3 Market size and forecast

4.5.4 Ultrasound

4.5.4.1 Market size and forecast

4.5.5 Electronic Fetal Monitoring devices (EFM)

4.5.5.1 Market size and forecast

4.5.6 Fetal Doppler

4.5.6.1 Market size and forecast

4.5.7 Others

4.5.7.1 Market size and forecast

4.6 RESPIRATORY MONITORS

4.6.1 Key market trends

4.6.2 Key growth factors and opportunities

4.6.3 Market size and forecast

4.6.4 Capnographs

4.6.4.1 Market size and forecast

4.6.5 Spirometers

4.6.5.1 Market size and forecast

4.6.6 Sleep apnea monitors

4.6.6.1 Market size and forecast

4.6.7 Pulse oximeters

4.6.7.1 Market size and forecast

4.7 MULTIPARAMETER MONITORING DEVICES

4.7.1 Key market trends

4.7.2 Key growth factors and opportunities

4.7.3 Market size and forecast

4.7.4 High acuity

4.7.4.1 Market size and forecast

4.7.5 Mid acuity

4.7.5.1 Market size and forecast

4.7.6 Low acuity

4.7.6.1 Market size and forecast

4.8 REMOTE PATIENT MONITORING DEVICES

4.8.1 Key market trends

4.8.2 Key growth factors and opportunities

4.8.3 Market size and forecast

4.9 WEIGHT MONITORING DEVICES

4.9.1 Key market trends

4.9.2 Key growth factors and opportunities

4.9.3 Market size and forecast

4.10 TEMPERATURE MONITORING DEVICES

4.10.1 Key market trends

4.10.2 Key growth factors and opportunities

4.10.3 Market size and forecast

 

5.1 OVERVIEW

5.1.1 Market size and forecast

5.2 HOSPITALS AND CLINICS

5.2.1 Market size and forecast

5.3 HOME SETTINGS

5.3.1 Market size and forecast

5.4 AMBULATORY SURGICAL CENTERS (ASC)

5.4.1 Market size and forecast

 

6.1 OVERVIEW

6.1.1 Market size and forecast

6.2 NORTH AMERICA

6.2.1 Market size and forecast

6.3 EUROPE

6.3.1 Market size and forecast

6.4 ASIA-PACIFIC

6.4.1 Market size and forecast

6.5 LAMEA

6.5.1 Market size and forecast

 

7.1 BIOTRONIK SE & CO. KG

7.1.1 Company overview

7.1.2 Company snapshot

7.1.3 Operating business segments

7.1.4 Key strategic moves and developments

7.2 KONINKLIJKE PHILIPS N.V.

7.2.1 Company overview

7.2.2 Company snapshot

7.2.3 Operating business segments

7.2.4 Business performance

7.2.5 Key strategic moves and developments

7.3 GENERAL ELECTRIC COMPANY

7.3.1 Company overview

7.3.2 Company snapshot

7.3.3 Operating business segments

7.3.4 Business performance

7.3.5 Key strategic moves and developments

7.4 NIHON KOHDEN CORPORATION

7.4.1 Company overview

7.4.2 Company snapshot

7.4.3 Operating business segments

7.4.4 Business performance

7.4.5 Key strategic moves and developments

7.5 MEDTRONIC PLC

7.5.1 Company overview

7.5.2 Company snapshot

7.5.3 Operating business segments

7.5.4 Business performance

7.5.5 Key strategic moves and developments

7.6 MASIMO CORPORATION

7.6.1 Company overview

7.6.2 Company snapshot

7.6.3 Operating business segments

7.6.4 Business performance

7.6.5 Key strategic moves and developments

7.7 ABBOTT LABORATORIES

7.7.1 Company overview

7.7.2 Company snapshot

7.7.3 Operating business segments

7.7.4 Business performance

7.7.5 Key strategic moves and developments

7.8 JOHNSON AND JOHNSON

7.8.1 Company overview

7.8.2 Company snapshot

7.8.3 Operating business segments

7.8.4 Business performance

7.8.5 Key strategic moves and developments

7.9 OMRON HEALTHCARE CO. LTD.

7.9.1 Company overview

7.9.2 Company snapshot

7.9.3 Operating business segments

7.9.4 Business performance

7.9.5 Key strategic moves and developments

7.10 F. HOFFMANN-LA ROCHE LTD.

7.10.1 Company overview

7.10.2 Company snapshot

7.10.3 Business performance

7.10.4 Key strategic moves and development

 

TABLE 1 CLINICAL TRIALS: PATIENT MONITORING DEVICES MARKET, 2013-2016

TABLE 2 PATENTS REGISTERED/APPROVED IN THE WORLD 2010-2016

TABLE 3 U.S.: PATENT ANALYSIS, BY MARKET PARTICIPANT, 2010-2016

TABLE 4 EUROPE: PATENT ANALYSIS, BY MARKET PARTICIPANT, 2010-2016

TABLE 5 CHINA: PATENT ANALYSIS, BY MARKET PARTICIPANT, 2010-2016

TABLE 6 CANADA: PATENT ANALYSIS, BY MARKET PARTICIPANT, 2010-2016

TABLE 7 JAPAN: PATENT ANALYSIS, BY MARKET PARTICIPANT, 2010-2016

TABLE 8 OTHERS: PATENT ANALYSIS, BY MARKET PARTICIPANT, 2010-2016

TABLE 9. GLOBAL PATIENT MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)

TABLE 10. HEMODYNAMIC MONITORING DEVICES MARKET, BY TYPE, 2016-2023 ($MILLION)

TABLE 11. HEMODYNAMIC MONITORING DEVICES MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)

TABLE 12. BLOOD GLUCOSE MONITORING DEVICES MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)

TABLE 13. BLOOD GAS & ELECTROLYTE ANALYSERS MONITORING DEVICES MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)

TABLE 14. BLOOD PRESSURE MONITORING DEVICES MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)

TABLE 15. NEUROMONITORING DEVICES MARKET, BY TYPE, 2016-2023 ($MILLION)

TABLE 16. NEUROMONITORING DEVICES MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)

TABLE 17. ELECTROENCEPHALOGRAPH MONITORING DEVICES MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)

TABLE 18. TRANSCRANIAL DOPPLERS MONITORING DEVICES MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)

TABLE 19. MAGNETOENCEPHALOGRAPH MONITORING DEVICES MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)

TABLE 20. INTRACRANIAL PRESSURE MONITORS MONITORING DEVICES MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)

TABLE 21. CEREBRAL OXIMETER MONITORING DEVICES MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)

TABLE 22. CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2016-2023 ($MILLION)

TABLE 23. CARDIAC MONITORING DEVICES MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)

TABLE 24. ELECTROCARDIOGRAM MONITORING DEVICES MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)

TABLE 25. HOLTER MONITORING DEVICES MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)

TABLE 26. EVENT MONITORING DEVICES MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)

TABLE 27. OTHER CARDIAC MONITORING DEVICES MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)

TABLE 28. FETAL AND NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2016-2023 ($MILLION)

TABLE 29. FETAL AND NEONATAL MONITORING DEVICES MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)

TABLE 30. ULTRASOUND MONITORING DEVICES MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)

TABLE 31. ELECTRONIC FETAL MONITORING DEVICES MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)

TABLE 32. FETAL DOPPLER MONITORING DEVICES MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)

TABLE 33. OTHER FETAL AND NEONATAL MONITORING DEVICES MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)

TABLE 34. RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2016-2023 ($MILLION)

TABLE 35. RESPIRATORY MONITORING DEVICES MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)

TABLE 36. CAPNOGRAPH MONITORING DEVICES MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)

TABLE 37. PULSE OXIMETER MONITORING DEVICES MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)

TABLE 38. SLEEP APNEA MONITORING DEVICES MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)

TABLE 39. SPIROMETER MONITORING DEVICES MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)

TABLE 40. MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2016-2023 ($MILLION)

TABLE 41. MULTIPARAMETER MONITORING DEVICES MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)

TABLE 42. HIGH ACUITY MULTIPARAMETER MONITORING DEVICES MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)

TABLE 43. MID ACUITY MULTIPARAMETER MONITORING DEVICES MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)

TABLE 44. LOW ACUITY MULTIPARAMETER MONITORING DEVICES MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)

TABLE 45. REMOTE PATEINT MONITORING DEVICES MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)

TABLE 46. WEIGHT MONITORING DEVICES MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)

TABLE 47. TEMPERATURE MONITORING DEVICES MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)

TABLE 48. GLOBAL PATIENT MONITORING DEVICES MARKET, BY END USERS, 2016-2023 ($MILLION)

TABLE 49. PATIENT MONITORING DEVICES MARKET IN HOSPITALS, BY GEOGRAPHY, 2016-2023 ($MILLION)

TABLE 50. PATIENT MONITORING DEVICES MARKET IN HOME SETTING, BY GEOGRAPHY, 2016-2023 ($MILLION)

TABLE 51. PATIENT MONITORING DEVICES MARKET IN AMBULATORY SURGICAL CENTERS, BY GEOGRAPHY, 2016-2023 ($MILLION)

TABLE 52. GLOBAL PATIENT MONITORING DEVICES MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)

TABLE 53. NORTH AMERICA PATIENT MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)

TABLE 54. NORTH AMERICA PATIENT MONITORING DEVICES MARKET, BY END USER, 2016-2023 ($MILLION)

TABLE 55. NORTH AMERICA PATIENT MONITORING DEVICES MARKET, BY COUNTRY, 2016-2023 ($MILLION)

TABLE 56. EUROPE PATIENT MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)

TABLE 57. EUROPE PATIENT MONITORING DEVICES MARKET, BY END USER, 2016-2023 ($MILLION)

TABLE 58. EUROPE PATIENT MONITORING DEVICES MARKET, BY COUNTRY, 2016-2023 ($MILLION)

TABLE 59. ASIA-PACIFIC PATIENT MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)

TABLE 60. ASIA-PACIFIC PATIENT MONITORING DEVICES MARKET, BY END USER, 2016-2023 ($MILLION)

TABLE 61. ASIA-PACIFIC PATIENT MONITORING DEVICES MARKET, BY COUNTRY, 2016-2023 ($MILLION)

TABLE 62. LAMEA PATIENT MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2016-2023 ($MILLION)

TABLE 63. LAMEA PATIENT MONITORING DEVICES MARKET, BY END USER, 2016-2023 ($MILLION)

TABLE 64. LAMEA PATIENT MONITORING DEVICES MARKET, BY COUNTRY, 2016-2023 ($MILLION)

TABLE 65. BIOTRONIK: COMPANY SNAPSHOT

TABLE 66. BIOTRONIK: OPERATING SEGMENTS

TABLE 67. PHILIPS: COMPANY SNAPSHOT

TABLE 68. PHILIPS: OPERATING SEGMENTS

TABLE 69. GE: COMPANY SNAPSHOT

TABLE 70. GE: OPERATING SEGMENTS

TABLE 71. NIHON KOHDEN: COMPANY SNAPSHOT

TABLE 72. NIHON KOHDEN: PRODUCT OFFERINGS

TABLE 73. MEDTRONIC: COMPANY SNAPSHOT

TABLE 74. MEDTRONIC: OPERATING SEGMENTS

TABLE 75. MASIMO:COMPANY SNAPSHOT

TABLE 76. MASIMO: OPERATING SEGMENTS

TABLE 77. ABBOTT: COMPANY SNAPSHOT

TABLE 78. ABBOTT: PRODUCTS

TABLE 79. JOHNSON & JOHNSON :COMPANY SNAPSHOT

TABLE 80. JOHNSON & JOHNSON: OPERATING SEGMENTS

TABLE 81. OMRON: COMPANY SNAPSHOT

TABLE 82. OMRON: PRODUCT OFFERINGS

TABLE 83. ROCHE: COMPANY SNAPSHOT FIG. 1 TOP INVESTMENT POCKETS: WORLD PATIENT MONITORING DEVICES MARKET, BY DEVICE TYPE

FIG. 2 TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION (2014-2016)

FIG. 3 TOP WINNING STRATEGIES: NATURE AND TYPE (2014-2016)

FIG. 4 PATENTS REGISTERED/APPROVED IN THE WORLD 2010-2016

FIG. 5 U.S.: PATENT ANALYSIS, BY MARKET PARTICIPANT, 2010-2016

FIG. 6 EUROPE: PATENT ANALYSIS, BY MARKET PARTICIPANT, 2010-2016

FIG. 7 CHINA: PATENT ANALYSIS, BY MARKET PARTICIPANT, 2010-2016

FIG. 8 CANADA: PATENT ANALYSIS, BY MARKET PARTICIPANT, 2010-2016

FIG. 9 JAPAN: PATENT ANALYSIS BY MARKET PARTICIPANT, 2010-2016

FIG. 10 OTHERS: PATENT ANALYSIS, BY MARKET PARTICIPANT, 2010-2016

FIG. 11 TOP IMPACTING FACTORS

FIG. 12. U.S. PATIENT MONITORING Devices Market, 2016-2023 ($MILLION)

FIG. 13. CANADA PATIENT MONITORING Devices Market, 2016-2023 ($MILLION)

FIG. 14. MEXICO PATIENT MONITORING Devices Market, 2016-2023 ($MILLION)

FIG. 15. GERMANY PATIENT MONITORING Devices Market, 2016-2023 ($MILLION)

FIG. 16. FRANCE PATIENT MONITORING Devices Market, 2016-2023 ($MILLION)

FIG. 17. UK PATIENT MONITORING Devices Market, 2016-2023 ($MILLION)

FIG. 18. ITALY PATIENT MONITORING Devices Market, 2016-2023 ($MILLION)

FIG. 19. REST OF EUROPE PATIENT MONITORING Devices Market, 2016-2023 ($MILLION)

FIG. 20. JAPAN PATIENT MONITORING Devices Market, 2016-2023 ($MILLION)

FIG. 21. CHINA PATIENT MONITORING Devices Market, 2016-2023 ($MILLION)

FIG. 22. AUSTRALIA PATIENT MONITORING Devices Market, 2016-2023 ($MILLION)

FIG. 23. INDIA PATIENT MONITORING Devices Market, 2016-2023 ($MILLION)

FIG. 24. REST OF ASIA-PACIFIC PATIENT MONITORING Devices Market, 2016-2023 ($MILLION)

FIG. 25. BRAZIL PATIENT MONITORING Devices Market, 2016-2023 ($MILLION)

FIG. 26. TURKEY PATIENT MONITORING Devices Market, 2016-2023 ($MILLION)

FIG. 27. SAUDI ARABIA PATIENT MONITORING Devices Market, 2016-2023 ($MILLION)

FIG. 28. SOUTH AFRICA PATIENT MONITORING Devices Market, 2016-2023 ($MILLION)

FIG. 29. REST OF LAMEA PATIENT MONITORING Devices Market, 2016-2023 ($MILLION)

FIG. 30. PHILIPS: REVENUE, BY YEAR ($MILLION)

FIG. 31. PHILIPS: REVENUE, BY SEGMENT, 2015 (%)

FIG. 32. PHILIPS: REVENUE, BY GEOGRAPHY, 2015 (%)

FIG. 33. GE: REVENUE, BY YEAR ($MILLION)

FIG. 34. GE: REVENUE, BY SEGMENT, 2015 (%)

FIG. 35. GE: HEALTHCARE REVENUE, BY SEGMENT, 2015 (%)

FIG. 36. GE: REVENUE, BY GEOGRAPHY, 2015 (%)

FIG. 37. NIHON KOHDEN: REVENUE, BY YEAR ($MILLION)

FIG. 38. NIHON KOHDEN: REVENUE, BY SEGMENT, 2015 (%)

FIG. 39. NIHON KOHDEN: REVENUE, BY GEOGRAPHY, 2015 (%)

FIG. 40. MEDTRONIC: REVENUE, BY YEAR ($MILLION)

FIG. 41. MEDTRONIC: REVENUE, BY SEGMENT, 2016 (%)

FIG. 42. MEDTRONIC: REVENUE, BY GEOGRAPHY, 2016 (%)

FIG. 43. MASIMO: REVENUE, BY YEAR ($MILLION)

FIG. 44. MASIMO: REVENUE, BY GEOGRAPHY, 2015 (%)

FIG. 45. ABBOTT: REVENUE, BY YEAR ($MILLION)

FIG. 46. ABBOTT: REVENUE, BY SEGMENT, 2015 (%)

FIG. 47. ABBOTT: REVENUE, BY GEOGRAPHY, 2015 (%)

FIG. 48. JOHNSON & JOHNSON: REVENUE, BY YEAR ($MILLION)

FIG. 49. JOHNSON & JOHNSON: REVENUE, BY SEGMENT, 2015 (%)

FIG. 50. JOHNSON & JOHNSON: REVENUE, BY GEOGRAPHY, 2015 (%)

FIG. 51. OMRON: REVENUE, BY YEAR ($MILLION)

FIG. 52. OMRON: REVENUE, BY SEGMENT, 2015 (%)

FIG. 53. OMRON: REVENUE, BY GEOGRAPHY, 2015 (%)

FIG. 54. ROCHE: NET SALES, 2013-2015 ($MILLION)

FIG. 55. ROCHE: REVENUE, BY SEGMENTS, 2015 (%)

FIG. 56. ROCHE: REVENUE, BY GEOGRAPHY, 2015 (%